DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFlu

Drug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news